Cell and Gene Therapy

[New Research] Why you shouldn't rely on one raw materials partner, but most developers still do

Raw materials are an increasing area of attention for advanced therapy developers, particularly as therapies hurtle towa... read more

Cell and Gene Therapy

[E-BOOK] Raw Materials at Scale: Success Factors for Commercial Cell and Gene Therapy Manufacturing

The case for achieving ancillary/raw material consistency and flexibility of deliverability for manufacturing partnershi... read more

Cell and Gene Therapy

Top Ten Events in Advanced Therapies 2020

 From a pandemic and record-breaking vaccine approvals to FDA rejections and a Nobel Prize; Phacilitate's annual top te... read more

Phacilitate Talks #9 Nina Bauer, MilliporeSigma and Lance Holland, bluebird bio - PART 2

Nina and Lance join us again to continue our discussion and share predictions on Mesoblast's FDA ruling 

Episode 8 - Women in Advanced Therapies Special with Tom & Emily Whitehead

The fourth in our series of Women in Advanced Therapies interviews. This is a very special episode in the series, in whi... read more

Episode 7 Nina Bauer, MilliporeSigma and Lance Holland, bluebird bio

Nina and Lance share their views on remotely managing CDMOs and recruiting and retaining diverse talent